<DOC>
	<DOCNO>NCT02108678</DOCNO>
	<brief_summary>The purpose research study examine whether one-day group workshop , integrate principle Acceptance Commitment Therapy Migraine Education , result great improvement depressive symptom function impairment patient comorbid migraine depression similar one-day group workshop Migraine Education .</brief_summary>
	<brief_title>One-Day Intervention Depression Impairment Migraine Patients</brief_title>
	<detailed_description>Adults comorbid depression migraine randomize 1-day ( 6-hour ) workshop Acceptance Commitment Training + Migraine Education ( ACT-ME ) Migraine Education ( MEO ) . The intervention deliver study arm identical except addition ACT component deliver ACT-ME condition , thereby allow estimate specific additive effect psychotherapy . Measures acceptance behavioral avoidance , theoretically important mechanism change , use test intervention component examine whether process uniquely affect ACT-ME intervention whether account observe treatment effect . The central hypothesis ACT-ME treatment lead significantly great reduction depression ( HRSD ) disability ( WHO-DAS , WHOQOL , HDI ) follow-up compare MEO treatment . ACT-ME participant also expect demonstrate reduction behavioral avoidance enhance acceptance , mediate treatment effect . Treatment gain expect maintained 6-month follow-up . Aim 1 : To examine efficacy 1-day ACT-ME intervention compare MEO treat depression patient comorbid depression migraine . Hypothesis 1 : At 3- 6-month follow-up , ACT-ME efficacious MEO assess : 1 ) significantly great decline Hamilton Rating Scale Depression ( HRSD ) total score ; 2 ) significantly high proportion participant show 50 % great decline HRSD ; 3 ) significantly high proportion participant longer meet depression criterion SCID-IV . Aim 2 : To examine efficacy 1-day ACT-ME intervention compare MEO function patient comorbid depression migraine . Hypothesis 2 : At 3- 6-month follow-up , compare MEO group , participant ACT-ME group exhibit significantly great improvement functioning ( measure World Health Organization Disability Assessment Schedule-Total Score ; WHO-DAS ) quality life ( measure World Health Organization Quality Life Total ; WHO-QOL ) , great decline headache-related disability ( measure Headache Disability Inventory ; HDI ) . Aim 3 : To determine whether change acceptance-based cop behavioral avoidance mediate change depressive symptom disability . Hypothesis 3 : Increases acceptance-based cop reduction behavioral avoidance mediate relation treatment group 1 ) decline depressive symptom measure HRSD 2 ) disability , measure WHO-DAS HDI . Acceptance Behavioral Avoidance measure use Acceptance Action Questionnaire Chronic Pain Acceptance Questionnaire .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>Ages 1865 Current major depressive episode SCIDIV ( 46 ) Score â‰¥ 17 HRSD ( 47 ) Confirmation diagnosis migraine medical record 412 migraine previous month Bipolar , psychotic , current substance use disorder History brain injury Imminent suicidality .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Acceptance Commitment Therapy ( ACT )</keyword>
	<keyword>Depression</keyword>
	<keyword>Illness Management</keyword>
	<keyword>Behavioral Treatment</keyword>
	<keyword>Impairment</keyword>
</DOC>